A South Korean court on Thursday found former president Yoon Suk-yeol guilty of insurrection over his short-lived martial law decree that plunged the country into its most serious constitutional crisis in decades. The verdict, delivered by a three-judge panel of the Seoul Central District Court’s Criminal Division 25, was the harshest and most consequential ruling yet stemming from Yoon’s brief im...
A South Korean court on Thursday found former president Yoon Suk-yeol guilty of insurrection over his short-lived martial law decree that plunged the country into its most serious constitutional crisis in decades. The verdict, delivered by a three-judge panel of the Seoul Central District Court’s Criminal Division 25, was the harshest and most consequential ruling yet stemming from Yoon’s brief imposition of martial law on December 3, 2024, and the events leading up to it. The court found that...
Compass Pathways ( CMPS ) priced its public offering of 17.5M ADSs at $8.00 per ADS. It also offered pre-funded warrants to purchase up to 1.25M ADSs at $7.9999 each to certain institutional investors, with underwriters granted a 30-day option for an additional 2.8125M ADSs. The gross proceeds are expected to total $150M, with closing anticipated on or about February 20, 2026. The net proceeds wil...
Compass Pathways ( CMPS ) priced its public offering of 17.5M ADSs at $8.00 per ADS. It also offered pre-funded warrants to purchase up to 1.25M ADSs at $7.9999 each to certain institutional investors, with underwriters granted a 30-day option for an additional 2.8125M ADSs. The gross proceeds are expected to total $150M, with closing anticipated on or about February 20, 2026. The net proceeds will fund ongoing Phase 3 trials COMP005 and COMP006 (likely for treatment-resistant depression), a Phase 2b/3 trial of COMP360 psilocybin for PTSD, commercial readiness acceleration, and general corporate purposes. More on COMPASS Pathways ADS COMPASS Pathways plc (CMPS) Discusses Positive Phase III Results for COMP360 in Treatment-Resistant Depression Trials Transcript Compass Pathways: Stock Soars As Data Sets Up Psilocybin Approval Shot COMPASS Pathways plc (CMPS) Discusses Positive Phase III Results for COMP360 in Treatment-Resistant Depression Trials - Slideshow Compass Pathways launches proposed $150 million public offering Compass gains as psychedelic therapy succeeds in late-stage trial for depression
Sundry Photography/iStock Editorial via Getty Images In the span of just a few short weeks, software stocks have gone from being prized for potential AI tailwinds to being discarded for fear of being replaced by AI. The speed of the selloff is what has jarred mainstream investors, with many high-profile leading software businesses erasing years of gains in a very compressed period. Few stocks have...
Sundry Photography/iStock Editorial via Getty Images In the span of just a few short weeks, software stocks have gone from being prized for potential AI tailwinds to being discarded for fear of being replaced by AI. The speed of the selloff is what has jarred mainstream investors, with many high-profile leading software businesses erasing years of gains in a very compressed period. Few stocks have been as challenged as Atlassian ( TEAM ), the software giant known for its Jira IT management and collaboration tools. Atlassian has lost ~40% of its value since the start of the year alone, and over the past year, the stock has shed about two-thirds of its value, wiping off billions in market cap. The question for investors now is, is Atlassian’s future truly jeopardized by AI, or is this a clear signal of an oversold stock that should be bought? Data by YCharts I last wrote a "Buy" article on Atlassian in November, when the stock was trading near $160 per share. Needless to say, Atlassian has been a major hole in my portfolio, and I did not expect such massive volatility. And yet, when I take a step back and assess the stock soberly now, it’s evident that the recent crash is almost entirely due to sentiment rather than due to fundamentals. Atlassian was one of the earliest software stocks to begin correcting, with shares already souring midway through 2025 on fears that vibe coding would lead to an erosion of the software developer jobs that constitute the company’s core paid seat count. This doomsday scenario has not happened, and I’m happy to take the opportunity to dollar cost average my position downward and buy Atlassian at decimated multiples of revenue and earnings. With this in mind, I’m upgrading the stock to a "Strong Buy." To me, there are several indicators that clearly show that Atlassian’s actual business remains quite secure and in growth mode, despite recent selloff fears. These are the core catalysts that investors need to be paying attention to, rather ...
Garmin ( GRMN ) declares $1.05/share monthly dividend , 16.7% increase from prior dividend of $0.90. Forward yield 5.31% Payable June 26; for shareholders of record June 15; ex-div June 15. Payable Sept 25; for shareholders of record Sept 11; ex-div Sept 11. Payable Dec 24; for shareholders of record Dec 11; ex-div Dec 11. Payable March 26; for shareholders of record March 12; ex-div March 12. See...
Garmin ( GRMN ) declares $1.05/share monthly dividend , 16.7% increase from prior dividend of $0.90. Forward yield 5.31% Payable June 26; for shareholders of record June 15; ex-div June 15. Payable Sept 25; for shareholders of record Sept 11; ex-div Sept 11. Payable Dec 24; for shareholders of record Dec 11; ex-div Dec 11. Payable March 26; for shareholders of record March 12; ex-div March 12. See GRMN Dividend Scorecard, Yield Chart, & Dividend Growth. More on Garmin Garmin Ltd. (GRMN) Q4 2025 Earnings Call Transcript Garmin: Fitness And Aviation Are The Stars In The Future (Q4 Review) Garmin Ltd. 2025 Q4 - Results - Earnings Call Presentation Garmin projects 9% revenue growth to $7.9B in 2026 while emphasizing consolidated guidance Garmin beats top-line and bottom-line estimates; initiates FY26 outlook
Earnings Call Insights: Herbalife Ltd. (HLF) Q4 2025 Management View CEO Stephan Gratziani reflected on 2025 performance, emphasizing reductions in total leverage ratio to 2.8x from 3.9x, stating, "This meaningful step down... underscores the strength of our business and our strong sustainable cash generation." He highlighted consecutive quarters of net sales growth, with Q4 net sales at $1.3 bill...
Earnings Call Insights: Herbalife Ltd. (HLF) Q4 2025 Management View CEO Stephan Gratziani reflected on 2025 performance, emphasizing reductions in total leverage ratio to 2.8x from 3.9x, stating, "This meaningful step down... underscores the strength of our business and our strong sustainable cash generation." He highlighted consecutive quarters of net sales growth, with Q4 net sales at $1.3 billion, up 6.3%, and noted, "India delivered its highest quarterly net sales in Q4. And even without India's outperformance, our Q4 net sales would have still come in above the midpoint of our guidance range." Gratziani announced a new partnership: "Global sports icon Cristiano Ronaldo has acquired a 10% equity stake in HBL Pro2col Software... Cristiano invested $7.5 million, along with the commitment to provide services and sponsorship rights to Pro2col." Product innovation was underscored with the launch of MultiBurn for weight management, HL/Skin in EMEA supported by an AI-powered facial analysis tool, and the expansion into healthy lifespan with Life I/O Baseline. He also detailed the phased beta rollout and expansion of Pro2col, the company’s digital health and wellness operating system, with plans for personalized nutritional supplements to be accessible in the U.S. by the end of the first half of 2026. CFO John DeSimone stated, "Net sales for the fourth quarter were $1.3 billion, with 6.3% growth versus Q4 of 2024 and exceeding the high end of our guidance of 1.5% to 5.5% year-over-year growth." Outlook Herbalife projects first quarter 2026 net sales growth of 3% to 7% year-over-year on a reported basis and 0.5% to 4.5% on a constant currency basis. Adjusted EBITDA for Q1 is expected to be between $155 million and $175 million. Full year 2026 reported net sales growth is expected to range from 1% to 6%, with a constant currency expectation of flat to up 5% year-over-year. Adjusted EBITDA for the year is forecasted between $670 million and $710 million, and capital expen...
Key PointsThe Vanguard Mega Cap Growth ETF tracks the performance of the CRSP U.S. Mega Cap Growth Index, which holds 65 of America's top growth companies.
Key PointsThe Vanguard Mega Cap Growth ETF tracks the performance of the CRSP U.S. Mega Cap Growth Index, which holds 65 of America's top growth companies.
(RTTNews) - Amundi S.A. (AMUN.PA, AMDUF), a French asset management company and investment firm, said on Thursday that it has obtained regulatory approval to appoint a director to ICG's board and will consolidate its stake using the equity method from March 31.
(RTTNews) - Amundi S.A. (AMUN.PA, AMDUF), a French asset management company and investment firm, said on Thursday that it has obtained regulatory approval to appoint a director to ICG's board and will consolidate its stake using the equity method from March 31.
India’s state-run banks are bucking a broader foreign pullback from the country’s equities, drawing inflows as lenders offer better valuations and stronger growth prospects. Foreign investors increased their stake in top state-run lenders including State Bank of India Ltd. , Bank of Baroda , Canara Bank Ltd. and Punjab National Bank to the highest in at least a year, shareholding data of as Dec. 3...
India’s state-run banks are bucking a broader foreign pullback from the country’s equities, drawing inflows as lenders offer better valuations and stronger growth prospects. Foreign investors increased their stake in top state-run lenders including State Bank of India Ltd. , Bank of Baroda , Canara Bank Ltd. and Punjab National Bank to the highest in at least a year, shareholding data of as Dec. 31 show. The optimism has extended into 2026, with a gauge tracking these companies gaining 12% from the start of the year to emerge as the best performing sectoral index. The resilience of state banks contrasts with $19 billion of net foreign outflows from the nation’s equities last year, signaling global funds are reallocating toward areas seen as offering steadier earnings visibility and insulation from AI-driven volatility. Many of these lenders have also reduced bad loans while showing a growth in credit. “These banks have caught up with private banks in digitizing operations — and the impact is now showing up in their performance,” said Kranthi Bathini , a strategist at WealthMills Securities Pvt. “The street is now finding promise in these firms, and that has narrowed their valuation discount relative to peers.” The Nifty PSU Index now trades at nearly 11 times its one-year forward earnings, compared to about 15 times for the Nifty Bank Index. This comes as foreigners’ overall holding in the NSE 500 Index fell to 18.1% as of Dec. 31, the lowest level in several years, according to IIFL Capital. Derivatives data suggest the bullish momentum in banks may continue. On Tuesday, three of the five most-active banking options were tied to state-run lenders, with traders buying call options in Bank of Baroda, Punjab National Bank and Union Bank of India — signaling expectations for further gains. The trend continued on Wednesday. Asia Investors Turn to Banks as AI Rattles Tech: Taking Stock India’s SBI Tops Market Value of Tech Giant TCS After 15 Years GQG Has $24 Billion in ...
Insight with Haslinda Amin, a daily news program featuring in-depth, high-profile interviews and analysis to give viewers the complete picture on the stories that matter. The show features prominent leaders spanning the worlds of business, finance, politics and culture. (Source: Bloomberg)
Insight with Haslinda Amin, a daily news program featuring in-depth, high-profile interviews and analysis to give viewers the complete picture on the stories that matter. The show features prominent leaders spanning the worlds of business, finance, politics and culture. (Source: Bloomberg)
(RTTNews) - Knorr-Bremse AG (KNBHF.PK, KNRRY.PK), a German manufacturer of braking systems, reported Thursday significantly higher profit in its fourth quarter amid relatively flat revenues and lower orders. The company said it achieved its guidance for fiscal 2025.
(RTTNews) - Knorr-Bremse AG (KNBHF.PK, KNRRY.PK), a German manufacturer of braking systems, reported Thursday significantly higher profit in its fourth quarter amid relatively flat revenues and lower orders. The company said it achieved its guidance for fiscal 2025.